The amount of aggregate purchase price for sale of accounts receivables.

No definition available.

Name:	cntg_AccountsReceivableAggregatePurchasePrice
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Represents the number of tranches in which the purchase price for sale of accounts receivable is payable.

+ References

No definition available.

+ Details

Name:	cntg_AccountsReceivableNumberOfTranches
Namespace Prefix:	cntg_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents the amount of purchase price of accounts receivable to be received under the each tranche.

+ References

No definition available.

+ Details

Name:	cntg_AccountsReceivablePurchasePriceInEachTranche
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of convert period.

+ References

No definition available.

+ Details

Name:	cntg_ConvertTerm
Namespace Prefix:	cntg_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of first operational milestone fee receivable.

+ References

No definition available.

+ Details

Name:	cntg_FirstMilestoneFeeReceivable
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The price per share of the conversion feature embedded in the debt instrument.

+ References

No definition available.

+ Details

Name:	cntg_IfrsDebtInstrumentConvertibleConversionPrice
Namespace Prefix:	cntg_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The first amount of conversion of the aggregate principal amount.

+ References

No definition available.

+ Details

Name:	cntg_NotionalAmountFirstAmountOfConversion
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The second amount of conversion of the aggregate principal amount.

+ References

No definition available.

+ Details

Name:	cntg_NotionalAmountSecondAmountOfConversion
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares agreed to sell under the joint venture.

+ References

No definition available.

+ Details

Name:	cntg_NumberOfSharesAgreedToSellInJointVenture
Namespace Prefix:	cntg_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage multiplied to the notional amount of debt in calculating the fee.

+ References

No definition available.

+ Details

Name:	cntg_PercentageMultipliedToNotionalAmountInCalculatingFee
Namespace Prefix:	cntg_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the percentage of interest in joint venture disposed.

+ References

No definition available.

+ Details

Name:	cntg_PercentageOfInterestInJointVentureSold
Namespace Prefix:	cntg_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the percent of royalty fees.

+ References

No definition available.

+ Details

Name:	cntg_PercentageOfRoyaltyFee
Namespace Prefix:	cntg_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The threshold consecutive trading days requirement in which amount of market capitalization should exceed the limit that would trigger the success fee.

+ References

No definition available.

+ Details

Name:	cntg_ThresholdConsecutiveTradingDaysOfMarketCapitalizationAmountRequirementThatWouldTriggerSuccessFee
Namespace Prefix:	cntg_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The threshold amount of market capitalization that would trigger the success fee.

+ References

No definition available.

+ Details

Name:	cntg_ThresholdMarketCapitalizationAmountThatWouldTriggerSuccessFee
Namespace Prefix:	cntg_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The threshold percentage of holding considered for making adjustment to the conversion price to the extent required to ensure compliance.

+ References

No definition available.

+ Details

Name:	cntg_ThresholdPercentageConsideredForConversionPriceAdjustment
Namespace Prefix:	cntg_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from sales of interests in joint ventures (other than receipts for those instruments considered to be cash equivalents and those held for dealing or trading purposes), classified as investing activities. [Refer: Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_d&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 21
-Subparagraph a
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ProportionOfOwnershipInterestInJointVenture
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ifrs-full_JointVenturesAxis=cntg_GenomicsInnovationsCompanyLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=cntg_PharmaceuticalInvestmentCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_ReceivableTransferAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=cntg_PharmaceuticalInvestmentCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_SaleOfInterestInJointVentureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_ModificationOfTechnologyTransferAndIntellectualPropertyLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_LoanAndSecurityAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_SecondLoanAmendmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_BorrowingsByNameAxis=cntg_AmendedConvertibleLoanAgreementWithLiferaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=cntg_ConversionOfFirstAmountMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=cntg_ConversionOfSecondAmountMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=cntg_ConsultancyVariationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) $ / shares in Units, € in Millions, ر.س in Millions, $ in Millions						12 Months Ended
	May 12, 2024 USD ($) D tranche $ / shares shares	May 12, 2024 EUR (€) D shares	May 12, 2024 SAR (ر.س) D shares	May 11, 2024 SAR (ر.س)	Jun. 26, 2023	Dec. 31, 2023	May 12, 2024 EUR (€) tranche	May 12, 2024 SAR (ر.س) tranche	May 11, 2024 $ / shares
Subsequent Event
Convert period	10 days	10 days	10 days
Genomics Innovations Company Limited
Subsequent Event
Proportion of ownership interest in joint venture					20.00%	20.00%
Genomics Innovations Company Limited \| Pharmaceutical Investment Company
Subsequent Event
Proportion of ownership interest in joint venture					80.00%
Receivable Transfer Agreement \| Pharmaceutical Investment Company
Subsequent Event
Aggregate purchase price	$ 15.0						€ 13.9
Number of tranches \| tranche	3						3	3
Purchase price in each tranche	$ 5.0
Sale of Interest in Joint Venture \| Genomics Innovations Company Limited \| Pharmaceutical Investment Company
Subsequent Event
Shares sells	16.00%	16.00%	16.00%
Transaction amounted		€ 4.9	ر.س 20.0
Number of shares agreed to sell under the joint venture \| shares	16,000	16,000	16,000
Proportion of ownership interest in joint venture	4.00%	4.00%	4.00%
Modification of Technology Transfer and Intellectual Property License Agreement
Subsequent Event
Percentage of royalty fee	1.00%	1.00%	1.00%	2.50%
Loan and Security Agreement
Subsequent Event
Percentage multiplied to notional amount in calculating fee	2.00%	2.00%	2.00%
Threshold market capitalization amount that would trigger success fee	$ 125.0
Threshold consecutive trading days of market capitalization amount requirement that would trigger success fee \| D	10	10	10
Second loan amendment
Subsequent Event
Second conversion of the aggregate principal amount	$ 15.0
Second loan amendment \| Amended convertible loan agreement with Lifera
Subsequent Event
Conversion of the aggregate principal amount	15.0
Second conversion of the aggregate principal amount	$ 15.0
Convert period	10 days	10 days	10 days
Threshold percentage, considered for conversion price adjustment	49.00%	49.00%	49.00%
Second loan amendment \| Amended convertible loan agreement with Lifera \| First Conversion
Subsequent Event
Conversion price \| $ / shares	$ 0.79								$ 2.20
Second loan amendment \| Amended convertible loan agreement with Lifera \| Second Conversion
Subsequent Event
Conversion price \| $ / shares	$ 2.20
Consultancy Variation Agreement
Subsequent Event
First milestone fee receivable \| ر.س				ر.س 20.0				ر.س 10.0